Delivering Value for Injectables: Unmet Needs, Device Solutions and Therapy Outcomes

Printer-friendly version

What constitutes value today for an injectable therapy? While upfront price will always be important, multiple other factors are being used by healthcare stakeholders to determine how a particular brand of injectable therapy should be valued against its competition. This article examines how and why pharmaceutical companies are leveraging innovative delivery systems to enhance and differentiate their injectable products so that they can generate powerful value-based healthcare outcomes amongst payers, prescribers and patients. To read more, click here: http://www.ondrugdelivery.com/publications/61/Unilife.pdf